OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
ORAGENICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.42−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $1.87M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Oragenics has not reported a dividend
No dividend per share appears in Oragenics's annual filings since fiscal 2010.